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A B S T R A C T
Feline infectious peritonitis (FIP) continues to be one of the most researched infectious diseases of cats.
The relatively highmortality of FIP, especially for younger cats from catteries and shelters, should be reason
enough to stimulate such intense interest. However, it is the complexity of the disease and the grudging
manner in which it yields its secrets that most fascinate researchers. Feline leukemia virus infection was
conquered in less than two decades and the mysteries of feline immunodeﬁciency virus were largely un-
raveled in several years. After a half century, FIP remains one of the last important infections of cats for
which we have no single diagnostic test, no vaccine and no deﬁnitive explanations for how virus and host
interact to cause disease. How can a ubiquitous and largely non-pathogenic enteric coronavirus trans-
form into a highly lethal pathogen? What are the interactions between host and virus that determine
both disease form (wet or dry) and outcome (death or resistance)? Why is it so diﬃcult, and perhaps
impossible, to develop a vaccine for FIP?What role do genetics play in disease susceptibility? This review
will explore research conducted over the last 5 years that attempts to answer these and other ques-
tions. Although much has been learned about FIP in the last 5 years, the ultimate answers remain for yet
more studies.
© 2014 The Author. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Introduction
Feline infectious peritonitis (FIP) continues to be a major killer
of young cats and is one of the most researched infections of the
species. Over 100 published articles concerning FIP have appeared
in theworld’s literature since the last extensive review of the disease
(Pedersen, 2009). Many of these and earlier publications have been
covered in excellent clinical (Addie et al., 2009; Drechsler et al., 2011)
and scientiﬁc (Myrrha et al., 2011; Kipar and Meli, 2014) reviews.
The goal of the present review is not to retrace old tracks, but rather
to present old and new discoveries on FIP in a different light.
FIP is a relatively new disease of cats and only became clinical-
ly signiﬁcant in the late 1950s (Pedersen, 2009). It is uncertain where
the ﬁrst FIP virus (FIPV) came from, but one possibility is that feline
coronaviruses originated within the century from another host
species. Alternatively, it is possible that contemporary feline
coronaviruses are genetic variants of a preexisting and somewhat
different virus species that was less prone to undergo biotype con-
version. Both scenarios are known to occur with coronaviruses. The
intestinal form of coronavirus in pigs has been replaced world-
wide by a much less pathogenic pneumotropic strain (Rasschaert
et al., 1990), while several coronaviruses have entered human beings
from other mammalian hosts (Chan et al., 2013).
We also cannot discount the important changes that occurred
in the status and husbandry of cats in the period after World War
II and how they affect FIP incidence. Cats have grown steadily in
numbers as pets, and pedigreed cats and catteries have increased
greatly in popularity. The post-war urban and suburban sprawl has
greatly increased the numbers of feral and semi-feral (communi-
ty) cats, and resulted in large numbers of kittens and cats coming
into shelters and other foster/rescue organizations. An increasing
proportion of our pet cats now come from these types of multi-
cat environments, which can be stressful and favor fecal–oral trans-
mission at a very young age. It should not be surprising that
coronaviruses are now themost common pathogen identiﬁed in the
feces of cats (Sabshin et al., 2012).
Coronaviruses have adapted themselves over thousands of years
to virtually every species of mammals and birds, and are a common
cause of transient enteritis and respiratory disease. Prior to the last
decade, research interest in coronaviruses as pathogens has largely
been limited to poultry, pigs, cattle and cats (Hagemeijer et al., 2012).
However, with the emergence of severe acute respiratory syn-
drome (SARS) and Middle Eastern respiratory syndrome (MERS),
interest in coronaviruses as pathogens has dramatically increased,
along with levels of research funding. There are commonalities
betweenwhat has been learnedwith animal coronaviruses and these
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emerging and sometimes fatal human viruses. They are continu-
ously adapting themselves to new hosts, they readily recombinewith
closely related species to form new viruses, and they even change
cell tropisms and virulence within the same host.
Although there is still no cure or sure prevention for FIP, a great
deal has been learned about the disease in the last 5 years. The in-
ternal mutation theory, whereby a ubiquitous feline enteric
coronavirus (FECV) mutates into a FIPV, has been reconﬁrmed and
at least three speciﬁcmutations have nowbeen associatedwith the
FECV-to-FIPV biotype conversion. Much more is known about the
interaction of enteric and FIP biotypes with their speciﬁc and very
different host cells, and the radically different host response and clin-
ical outcomes they provoke. A number of new reagents have been
developed, allowing researchers to better understand these twobio-
types and their diseases, and hopefullymore are forthcoming. Nev-
ertheless, FIP remains one of themost complex of all viral infections
of cats.
Origin of feline infectious peritonitis viruses
Viral replication
It is not possible to understand the interrelationship of FECVs
and FIPVs without understanding how enveloped, positive, single-
stranded RNA viruses replicate (Hagemeijer et al., 2012). The genome
of feline coronaviruses consists of > 29,000 nucleotides and 11 open
reading frames (ORFs) encoding structural, non-structural and ac-
cessory genes. Coronaviruses attach to speciﬁc cell receptors through
a complimentary ligand on the spike or surface (S) protein. Once
attachment occurs, fusion with the cell membrane is dependent on
a separate fusion domain and a fusion peptide comprising two heptad
repeat regions (HR1 and HR2). The virus is then internalized and
the single positive strand of RNA is released into the cytosol.
The 5’ two thirds of the feline coronavirus genome consists of
two ORFs, ORF 1a and ORF 1b. Ribosomes initiate translation at the
beginning of ORF 1a and a proportion undergo frame shifting at the
junction of ORF 1a and 1b, resulting in polyprotein pp1ab. Ribo-
somes that do not frame shift produce polyprotein pp1a. These
polyproteins consist of approximately 16 non-structural proteins in-
volved in proteolytic processing, genome replication and subgenomic
mRNA synthesis.
The non-structural proteins of feline coronaviruses interact with
components of the endoplasmic reticulum and Golgi apparatus to
produce a replication–transcription complex. A RNA-dependent RNA
polymerase makes negative sense copies of the genome, as well as
subgenomic RNAs, which in turn serve as templates for the pro-
duction of positive strand mRNAs. Only positive-stranded RNAs are
capped and polyadenylated. The 3’ polyadenylation and 5’ cap struc-
tures mimic those of cellular mRNAs, enabling the virus to use the
cell’s own machinery for viral protein synthesis.
The nucleocapsid (N) protein plays an essential role in viral RNA
and protein synthesis, and virion assembly (Verheije et al., 2010).
Viruses undergoing assembly make their way to the cell surface
within membrane structures, where they are released by exocyto-
sis as mature virions (Almazán et al., 2004). In the process of mat-
uration, the viral envelope also incorporates proteins acquired from
various cell compartments. These added host constituents might aid
survival in the face of host defenses.
This strategy to produce viral proteins from nested subgenomic
mRNAs is highly eﬃcient. However, like any process involving RNA
polymerases, an error rate in the order of 1/10,000 nucleotides is
expected. To minimize errors, the large genome encodes a number
of non-structural proteins that ensure a higher ﬁdelity of replica-
tion (Hagemeijer et al., 2012). Nonetheless,mutations do occurwith
some frequency. Chang et al. (2012) comparedwhole virus sequenc-
ing of 11 FIPV-FECVpairs and observed substitutions in at least 2963
nucleotides, representing 10% of the genome. Of these 2963 nucle-
otides, 1187 occurred in ORF 1ab, 1246 in ORF S (encoding the S gly-
coprotein), 248 inORF3abc, 22 inORFE (encoding the small envelope
protein), 42 in ORF M (encoding the integral membrane protein),
113 in ORF N (encoding the N protein) and 106 in ORF 7ab. Other
types of mutations, leading to insertions, deletions and premature
stop codons, as well as recombinants, have also been observed in
vivo, both within and between hosts (Pedersen et al., 2009, 2012).
Phillips et al. (2013) studied themutation rate of FIPV strainWSU-
79-1146 in vitro after 1, 8 and 50 passages, followed by whole viral
genome sequencing at each passage level. They observed 21 pre-
dicted amino acid changes in ORF 1a/1b during this period in culture,
one predicted change in the S protein (which reverted back after
additional passages), four changes in ORF 3c and one each in ORFs
3a, M, N and 7a, and calculated the mutation rate to be 5–6 × 10−6
nucleotides/site/passage. This suggested that the genome was rel-
atively stable in vitro and in the absence of host and environmen-
tal selection pressures.
Feline coronavirus mutations that do not have a negative impact
on survival accumulate with time and can become dominant within
micro- and macro-environments, such as catteries and geograph-
ically distinct regions (Pedersen et al., 2009). Such mutations can
be used to track a speciﬁc coronavirus back to its most likely origin.
Recombination also adds to genetic variation between coronaviruses
and is commonwithin clades, within the same cat and between cats
(Pedersen et al., 2009, 2012). Recombination can even occur between
related coronaviruses from different animal species. The type (se-
rotype) II feline coronaviruses are an example of cross-species re-
combination that has occurred between the S gene region of type
I feline coronaviruses and canine coronavirus.
The proportion of types I and II FECVs, and therefore types I and
II FIPVs, varies across the world, although type I strains predomi-
nate. Duarte et al. (2009) studied the distribution of types I and II
FIPVs in a Portuguese cat population using a reverse transcriptase
(RT)-PCR assay that ampliﬁed the 3’ end of the genome encom-
passing the region of feline/canine coronavirus S gene recombina-
tion. In cats with FIP, type I coronavirus was present in 79% and type
II coronavirus in 3.5%, whereas the remaining 17.5% could not be
typed. These viral sequences were further analyzed using a hetero-
duplex mobility assay, which detected quasi-species in 17% of
samples. Phylogenetic analysis of type I sequences revealed high
genetic diversity among Portuguese and previously characterized
strains, while the tree for type II strains had higher genetic homo-
geneity than the tree for type I strains (Duarte et al., 2009).
The internal mutation theory
There is a general consensus that FIPVs arise by internal muta-
tion from FECVs in the same environment (Pedersen et al., 2009,
2012; Harley et al., 2013). Except in unusual circumstances (Wang
et al., 2013), the causative mutations occur independently within
each cat and each FIPV strain has unique genetic features (Pedersen
et al., 2009, 2012; Chang et al., 2012; Barker et al., 2013; Licitra et al.,
2013). Currently, three different genes have been associated with
the FECV-to-FIPV mutation or biotype conversion. Each mutation
is a result of positive selection pressures, initially for a switch from
enterocyte to monocyte/macrophage tropism, then ultimately for
infection, replication and survival in peritoneal macrophages in the
face of host immunity.
Mutations in the ORF 3c accessory gene
The ORF 3c accessory gene was the ﬁrst gene to be implicated
in FECV-to-FIPV conversion (Vennema et al., 1998), and these ﬁnd-
ings have been corroborated in subsequent studies (Poland et al.,
1996; Chang et al., 2010; Pedersen et al., 2012). Two thirds or more
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of FIPVs have ORF 3c mutations that lead to a truncated protein
product, i.e. nucleotide deletions and insertions leading to frame
shifting, and single nucleotide polymorphisms causing premature
stop codons (Pedersen et al., 2009; Chang et al., 2012; Hsieh et al.,
2013). The one third that do not have truncating mutations have an
increased number of nucleotide changes, leading to an accumula-
tion of non-synonymous amino acid changes in the 3’ terminus of
the gene (Pedersen et al., 2012). However, only truncating muta-
tions have a known effect on host cell tropism. Two independent
studies have conﬁrmed the absolute requirement of an intact ORF
3c for replication of feline coronavirus in the intestinal epithelium
(Chang et al., 2012; Pedersen et al., 2012). FIPVs with truncating ORF
3c mutations will not replicate in the gut epithelium, but will ef-
ﬁciently replicate in macrophages. FIPVs with non-truncating mu-
tations in the 3’ terminus of ORF 3c will replicate in the intestine,
but they do not appear to be infectious under experimental con-
ditions (Pedersen et al., 2012).
The function of the protein expressed by ORF 3c is unknown.
Hsieh et al. (2013) transiently expressed ORF 3c in macrophage-
like cells (Fcwf-4) and found that the protein was distributedmainly
in the perinuclear region. They then infected Fcwf-4 cells express-
ing the intact ORF 3c protein with FIPV NTU156 (Lin et al., 2013),
which has a functionally mutated ORF 3c gene. A signiﬁcant inhi-
bition of viral replication was observed relative to cells not express-
ing the ORF 3c protein; this inhibition did not involve autophagy.
The authors concluded that loss of a functional ORF 3c protein in
FIPVs could enhance viral replication in macrophage-like cells.
It might also be possible to infer functions to the ORF 3c gene
product by studying similar and better studied genes in other
coronaviruses. A GenBank BLAST1 search demonstrated 30% genetic
homology between feline coronavirus ORF 3c and SARS coronavirus
ORF 3a (Pedersen et al., 2009). Although the genetic homology is
low, the ORF 3c protein of feline coronavirus has a similar hydro-
philicity proﬁle to its ownmembrane (M) protein, and to the M and
ORF 3a proteins of SARS coronavirus (Oostra et al., 2006).
The SARS ORF 3a protein has pro-apoptotic properties involv-
ing both cells death receptor andmitochondrial pathways (McBride
and Fielding, 2012). Similar to FIPV ORF 3c, mutants of the SARS ORF
3a gene are frequently identiﬁed in diseased tissues and encode pro-
teins with shorter N termini than found in wild type (i.e. bat
coronavirus) forms (Tan et al., 2004). The most recent studies on
the ORF 3a protein of SARS coronavirus indicate that it forms a
cation-selective channel that is expressed in infected cells and is in-
volved in release of virions (Schwarz et al., 2011). Is it also possi-
ble thatmutations in FIPV ORF 3c protein inhibit apoptosis of infected
macrophages? Programmed cell death is a major factor in immu-
nity to viral infection of a cell.
Mutations in the S gene
The ﬁrst mutation in the S gene that was associatedwith the FIPV
biotype was reported by Chang et al. (2012), who sequenced and
compared the complete genomes of 11 FIPV-FECV pairs. A single
nucleotide change within the S gene encoding the fusion peptide
was present in 124/129 (96%) FIPVs from cats with the wet and dry
forms of FIP, but absent from 11 FECVs. A second mutation, two
nucleotides away, was also strongly associated with FIPVs. Either
or both of these two single base pair mutations were observed in
most FIPVs, but not in FECVs. These mutations, designated M1058L
and S1060A, causedminor changes in single amino acids within the
S protein in FIPVs (i.e. methionine to leucine at position 1058 and
serine to alanine at position 1060). The authors postulated that even
minor changes in amino acids might be responsible for the in-
creased macrophage tropism of FIPVs. Since these mutations were
only observed in FIPVs in diseased tissue and not in virus in feces,
it can also be assumed that these particular mutations occur outside
the intestine, possibly in monocytes/macrophages. Their role in
causing disease is unknown, but they are more likely to be in-
volved in macrophage infectivity than in subsequent host–virus
immune interactions.
A second set of S gene mutations was reported by Licitra et al.
(2013), who examinedmutations at the S1/S2 cleavage site of feline
coronaviruses. This site is cleaved by furin, a protein that pro-
cesses normal cellular precursor proteins into biologically active
forms and is found in large quantities in the Golgi network. Com-
pared to FECVs, all FIPVs had at least one single base mutation in
and around the S1/S2 cleavage domain. Thesemutationswere unique
to each FIPV and, depending on the number of mutations and exact
amino acids that were changed, affected the eﬃciency of cleavage
of the S protein by furin; in most cases, the eﬃciency was in-
creased, while in some cases it was decreased and in others it re-
mained unchanged. Mutations in the region of the S1/S2 cleavage
site were not universal to all FIPVs. Unlike the two single base pair
mutations described in the S region encoding the fusion peptide,
which were present in 96% of FIPV genomes examined (Chang et al.,
2012), only two thirds of the same genomes had mutations at the
S1/S2 cleavage site (Licitra et al., 2013).
There is evidence from a single cat that mutations in the region
of the S1/S2 cleavage site can occur early in the conversion of FECVs
to FIPVs (Licitra et al., 2013). Two cats in this study shed FECVs in
their feces for 2–3 years before one of them developed FIP. The same
single base pair mutation in the S1/S2 cleavage region was identi-
ﬁed in the fecal FECV and the FIPV from diseased tissues of the cat
that developed FIP, whereas this mutation was not present in the
cat that remained unaffected. These particular mutations may have
resulted from positive selection pressures related to the adapta-
tion of FECV for better replication in monocyte–macrophages, but
not in later processes involving host–virus interactions.
The above studies indicate that regions within the C terminus
of the protein encoded by the S gene may be important in the con-
version of FECVs to FIPVs. A type I FIPV (strain C3663) remained fully
virulent despite a 735 base pair deletion encoding a predicted 245
amino acid sequence in the N terminus (Terada et al., 2012); this
deletionwould not affect the fusion peptide or S1/S2 cleavage regions
of the S protein. This begs the question as to what is the role of the
N terminus of the S protein.
It is too soon to say whether all of the mutations relevant to the
FECV-to-FIPV transition have been found. Although we do not fully
understand how thesemutations function in disease, they do suggest
potential targets for antiviral drugs, such as protease inhibitors (Kim
et al., 2013) or viral ion channel blockers (Schwarz et al., 2011).
Mutations associated with feline infectious peritonitis virus virulence
Loss of virulence in FIPVs such as strain WSU-79-1146 has been
associatedwith largemutations encompassing almost the entire ORF
7b accessory gene (Herrewegh et al., 1995, 1998), as well as small
mutations, including those of only two nucleotide changes (Takano
et al., 2011a). Lin et al. (2009) sequenced and compared feline
coronavirus ORF 7b mutations in ascites or pleural effusions from
20 cats with effusive FIP and in feces from 20 clinically healthy FECV
infected cats. Thirty-two of the 40 sequences had an intact ORF 7b,
whereas 8/40 sequences had deletions of either three or 12 nucle-
otides. However, only 3/8 viruses with deletions were from cats with
FIP. Therefore, deletions in ORF 7b can occur naturally, as well as
in tissue culture, and can occur in both FECVs and FIPVs.
Loss of virulence associated with ORF 7b mutations in FIPVs has
also led to false assumptions regarding the importance of this ORF1 See: http://blast.ncbi.nlm.nih.gov/Blast.cgi.
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in FECV-to-FIPV conversion and the designation of feline coronavirus
strainWSU-79-1683 as a prototypic FECV, whichwas originally based
on cat infection studies comparing type IIWSU-79-1683, which does
not cause FIP, with WSU-79-1146, the prototypic type II FIPV
(Pedersen et al., 1984). The authors concluded that WSU-79-1683
did behave as a FECV. However, this conclusion is counterintuitive,
since according to the mutation theory the ORF 7bmutation should
have been inWSU-79-1146. Furthermore,WSU-79-1683 grew readily
in Crandell Rees feline kidney (CRfk) cells, while the enteric
coronavirus could not be cultured from infectious feces in any cell
line at the time. Sequencing of WSU-79-1683 also demonstrated a
mutated ORF 3c, whereas the ORF 3c of FECVs is always intact (Chang
et al., 2010). These ﬁndings led to the conclusion that the WSU-79-
1683 strainwas not a true FECV (Pedersen, 2009). This ﬁnding altered
the conclusions of many previous studies using WSU-79-1683 and
WSU-79-1146 as prototypic FECVs and FIPVs, respectively.
Dedeurwaerder et al. (2013a) tried to link ORF 7b with macro-
phage tropism and hence with the evolution of FIPVs by measur-
ing the replication kinetics of FIPVWSU-79-1146 and several speciﬁc
deletion mutants in monocyte cultures. The mutants lacked either
the ORF 3abc accessory genes (FIPV-Δ3), ORF 7ab (FIPV-Δ7) or both
ORF 3abc and ORF 7b (FIPV-Δ3Δ7). Growth of FIPV-Δ7 and FIPV-
Δ3Δ7 could not be sustained in monocyte cultures, whereas sus-
tained growth was observed in monocyte cultures infected with
intact FIPV WSU-79-1146. FIPV-Δ3 replicated in monocyte cul-
tures, but at a lower level than intact FIPVWSU-79-1146. The authors
concluded that ORF 7 is crucial for FIPV replication in monocytes/
macrophages. They also concluded that their ﬁndings support the
role of ORF 7b in the development of FIP and provide an explana-
tion as to why ORF 7b is almost always conserved in ﬁeld strains
of FIPV. However, they failed to note that ORF 7b is also highly con-
served in ﬁeld strains of FECV (Pedersen et al., 2009; Chang et al.,
2010). Therefore, it is true that loss of the integrity of ORF 7b (almost
always occurring during cell culture passage) will cause FIPVs to lose
virulence, but it is not true that ORF 7b mutations are involved in
FECV-to-FIPV transformation.
Alternatives to the internal mutation theory
A study by Brown et al. (2009) temporarily shook the founda-
tions of the internal mutation theory and was supported in theory,
but not in fact, by at least one other group (Licitra et al., 2013). Using
phylogenetic analyses of coronaviruses identiﬁed in a small number
of FIPV-infected and healthy cats in a regional shelter in New
England, USA, the authors purported to show the existence of two
distinct types of feline coronaviruses circulating independently in
the population tested; one type causing FIP and the other not. The
authors identiﬁed ﬁve non-contiguous amino acids in the M protein
of feline coronavirus that differentiated these two types. However,
the numbers of cats used to construct the phylogenetic trees were
inadequate and the authors failed to consider that many of the cats
originated fromdifferent geographic regions, thus introducing genetic
drift and population bias.
Several subsequent experiments using larger numbers of cats and
taking into consideration geographic bias failed to conﬁrm the ex-
istence of distinct FECV and FIPV types. A study from the Nether-
lands failed to show that the ﬁve amino acid sequence deﬁned
distinct virus types and concluded that FIPVs originate from FECVs
in the same environments (Chang et al., 2011). Additional studies
on a large population of cats, taking into consideration genetic dif-
ferences related to geographic origins, also failed to ﬁnd evidence
for the ‘two virus’ theory or any signiﬁcant genetic differences
between FIPVs and FECVs from the same environments (Pedersen
et al., 2012). A phylogenetic analysis of fecal and tissue coronaviruses
from an outbreak of FIP in a group of 20 cats also conﬁrmed that
strains of FIP-associated feline coronaviruseswere very closely related
to viruses identiﬁed in the feces of healthy cats in the same envi-
ronment (Barker et al., 2013). This study also provided no evi-
dence that genetically distinct virulent (FIPV) and avirulent (FECV)
strains of feline coronavirus were present during this outbreak.
Recombinant feline infectious peritonitis virus
Considerable information has been gained about mutations af-
fecting biotypes and virulence of feline coronaviruses using reverse
genetics. Haijema et al. (2003) generated a mutant of FIPV WSU-
79-1146 in which the S gene was replaced by that of murine hep-
atitis virus (MHV), which allowed recombinant virus to be selected
for in murine cells. In a second reverse process, the FIPV S gene was
reintroduced to permit growth in feline cells. The growth charac-
teristics of this reverse recombinant virus in tissue culture and its
virulence for cats were indistinguishable from that of the parental
virus, FIPVWSU-79-1146. This technique was then used to develop
an avirulent deletion mutant of FIPV WSU-79-1146 that was as-
sessed as a potential vaccine (Haijema et al., 2004).
Tekes et al. (2008, 2010, 2012) used a similar reverse genetics
technique, but with a replication competent molecular clone of the
type I FIPV Black strain, as well as the type II FIPV WSU-79-1146.
In their ﬁrst study, ORF 3abc of FIPV Black was replaced by a green
ﬂuorescent protein and luciferase so that the virus could be tracked
in CD14+ blood monocytes and dendritic cells (Tekes et al., 2008).
In a subsequent study, Tekes et al. (2010) demonstrated that re-
combinant feline coronaviruses expressing the type II S protein
acquire the ability to eﬃciently use feline aminopeptidase N for host
cell entry, while type I viruses use another host cell receptor. They
also noted that the recombinant virus containing the type II S gene
produced high levels of large plaque virus identical to wild type FIPV
WSU-79-1146. Therefore, both the growth kinetics and the eﬃ-
cient usage of aminopeptidase N as a cellular receptor for type II
feline coronaviruses were attributed solely to the S protein.
In their most recent study, Tekes et al. (2012) studied the viru-
lence of their earlier molecular clones in speciﬁc pathogen free (SPF)
cats inoculated via the intraperitoneal route. Both engineered viruses
established productive infection in cats, as determined by the de-
tection of viral RNA in feces and the induction of speciﬁc antibod-
ies, but neither induced FIP. Unfortunately, neither control wild type
FIPV Black, nor its recombinant, caused FIP. The authors deduced
that the mutation(s) responsible for the loss of virulence occurred
upon prior tissue culture passage and resided in ORFs 1a, M, N or
7ab, or the 3’-untranslated region (3’-UTR). In contrast, SPF cats in-
fected with wild type FIPV WSU-79-1146 and its replication com-
petent molecular clone exhibited clinical signs starting at 2–3weeks
post infection and one cat in each group had to be euthanased after
7 weeks. These two cats, along with two others, had typical lesions
of FIP at postmortem examination.
A full length genome sequence was obtained from one of the cats
infected with wild type FIPVWSU-79-1146. Nine nucleotide differ-
ences were observed in the infecting virus, with three non-
synonymous mutations in the S gene, one in the gene encoding
non-structural protein 3 (replicase gene) and one in the E gene. Sig-
niﬁcantly, the stop codon in the ORF 3c accessory gene was changed
to encode a glutamine residue, thus yielding an intact ORF 3c protein.
A full-length genomic sequence was also obtained from the spleen
and kidney of one cat infected with themolecular cloned virus. Two
non-synonymous nucleotide changes were identiﬁed in the virus
sequence from the spleen, while seven non-synonymous and three
silent changes were identiﬁed in the virus sequence from the kidney.
Restoration of ORF 3c was observed once again and viral RNA with
this genotypewas also detected in the feces of both cats. This ﬁnding
appeared to contradict earlier reports suggesting that only enteric
biotypes (FECVs) require an intact ORF 3c for intestinal replication
(Chang et al., 2010; Pedersen et al., 2012). However, FIPVs with intact
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ORF 3c genes have been found in the feces of cats with FIP, and these
viruses often have an increase in non-synonymousmutations in the
3’ terminus of ORF 3c (Pedersen et al., 2012). Tekes et al. (2012) dem-
onstrated the importance of extending this reverse genetics ap-
proach to pathogenic type I feline coronaviruses and the need to
generate recombinant FECVs that could be used to study early events
in natural FECV-to-FIPV evolution.
Feline enteric coronavirus infection studies
Three studies from different groups have addressed the behav-
ior of FECV infection and immunity in laboratory cats (Pedersen et al.,
2008; Kipar et al., 2010; Vogel et al., 2010). These experiments con-
ﬁrmed what had been previously observed in cats naturally in-
fected with FECVs. Primary FECV infection is largely subclinical or
associated with a transient and usually mild diarrhea and is cen-
tered in the lower small intestine and colon (Kipar et al., 2010; Vogel
et al., 2010). Large amounts of virus are shed in the feces for many
weeks and even months after initial infection, but with time most
cats cease shedding. There also appears to be a low level of FECV
in blood monocytes during initial infection (Kipar et al., 2010).
However, immunity is not always solid and, as antibody levels in
the blood decrease, many cats become susceptible to reinfection
(Pedersen et al., 2008). These secondary infections closely resem-
ble the primary infection.
The comparative importance of various feline enteric patho-
gens, including FECV, was studied by Sabshin et al. (2012) in 100
shelter cats. Fecal samples were collected within 24 h after admis-
sion in 50 normal cats and 50 catswith diarrhea, and tested by fecal
ﬂotation, antigen assays, PCR and electron microscopy for patho-
gens. Twelveentericpathogenswere identiﬁed, includingcoronavirus,
Clostridium perfringens enterotoxin A, Cryptosporidium spp., Giardia
spp., Cystoisospora spp., hookworms, ascarids, Salmonella spp.,
astrovirus, feline panleukopenia virus, calicivirus and Spirometra spp.
Interestingly, cats with diarrhea were no more likely to be infected
with one or more of these enteropathogens than cats with normal
feces (84% in both groups). Only FECV was signiﬁcantly more prev-
alent in cats with diarrhea than in normal cats (58% and 36%, re-
spectively). FECV was also the most common fecal pathogen, being
several timesmore common thananyother enteric pathogen studied.
Although numerous strains of FECV are found among cats
throughout the world, at least one population has remained sur-
prisingly free of infection. Cats in the Falkland Islands have no signs
of infection and attempts are being made to quarantine these cats
from an inadvertent introduction of the virus (Addie et al., 2012).
The long isolation of cats in the Falklands is indirect evidence that
coronaviruses might not have existed in cats at the time of their
transit to the island.
Research investigating the FECV-to-FIPV pathotype transforma-
tion has been hampered by an inability to grow FECV in tissue
culture. A group from Belgium might have solved this problem by
creating a long-term feline ileocyte/colonocyte cell line using simian
virus 40 T antigen/human telomerase reverse transcriptase for im-
mortalization (Desmarets et al., 2013). This cell line readily propa-
gated two strains of type I FECVs, while no infection was seen in
cultures inoculatedwith FIPV tissue homogenates. The fact that FIPVs
would not grow in this cell line supports the theory that FIPVs lose
tropism for the intestinal epithelium and that FECV is the main
biotype circulating among cats. The creation of this cell line will ﬁll
a large hole in the list of reagents needed to study the pathogenic
properties of FIPV.
Types I and II feline coronaviruses
FECVs, and therefore FIPVs, exist as two distinct types based on
both serology and sequencing. Type I FECVs/FIPVs are unique to cats,
while type II FECVs/FIPVs appear to be recombinants between type
I FECVs and the closely related canine coronaviruses. Serologic dif-
ferences are due to canine coronavirus S protein sequences encoded
by the ORF 3a and S gene regions (Pedersen et al., 2009). Type I
FECVs/FIPVs predominate in Europe and the Americas, while up to
25% or more feline coronaviruses from Asian countries are type II
(Sharif et al., 2010; An et al., 2011; Amer et al., 2012). The exact origin
of type II feline coronaviruses is unknown, but their genetic vari-
ability suggests that they are continuously being generated. The in-
dependent nature of these recombination events is indicated by the
varying genetic makeup of the ‘hybrid’ viruses. These recombina-
tion events are often highly complex. This is demonstrated by strains
such as NTU156 from Taiwan (Lin et al., 2013). This strain not only
contains an in-frame deletion of 442 nucleotides in ORF 3c, a mu-
tation associated with the FECV-to-FIPV biotype change, but also
two crossover events with recombination sites located in the RNA-
dependent RNA polymerase andM genes. This produced a new virus
with one-third of its genome originating from canine coronavirus.
Although not proven, it is widely assumed that type II FIPVs aremore
virulent than type I FIPVs (Lin et al., 2013; Wang et al., 2013), pos-
sibly associated with the ease with which they are propagated in
a number of cat and dog cell lines. Type II FIPVs might also be more
likely to be transmitted between cats and to be associated with out-
breaks of FIP, such as one described in a Taiwanese shelter (Wang
et al., 2013).
Transmission of feline infectious peritonitis virus
The question of whether FIPV is transmitted cat-to-cat (hori-
zontal transmission) or by internal mutation from FECV (vertical
transmission) has also been a topic of interest. There is no solid ev-
idence that cats with FIP readily transmit FIPV directly to other cats,
although the possibility has been suggested as an explanation for
rare mini-outbreaks of FIP (Pedersen, 2009). FIPV can cause disease
when fed to laboratory cats, and some experimentally infected cats
will shed low levels of FIPV-like virus (Pedersen et al., 2009, 2012).
However, such virus does not appear to be infectious when fed to
other cats (Pedersen et al., 2012). Some cats with naturally ac-
quired FIP can also shed either FECV or a coronavirus that appears
genetically similar to the FIPV within the same cats (Chang et al.,
2010). An outbreak of FIP in Taiwan associated with a type II FIPV
appeared to be transmissible, but was self-limiting, either due to
quarantine measures or more likely to genetic drift (Wang et al.,
2013). Sequential samples collected over time from this outbreak
documented the replacement of the original virus, which had an
intact ORF 3c, with viruses having functionally mutated ORF 3c. This
provided indirect evidence that ORF 3c mutations are more likely
to be associated with disease than with infectivity.
Immunopathogenesis
Our knowledge of the pathogenesis of FIP remains at a very basic
level (Pedersen, 2009; Myrrha et al., 2011). The working hypothe-
sis is that FECVsmutate in amanner that causes them to lose tropism
for enterocytes, while gaining tropism for macrophages. The exact
site where these mutations occur is unknown, but it is apparently
at some point between the intestine (enterocyte) and FIP lesions
(macrophage). A possible intermediate site for this transforma-
tion would be blood monocytes/macrophages, which are known to
be infected during FECV infection (Kipar et al., 2010). FECV-to-
FIPV transition appears to involve positive selection for mutants that
are increasingly ﬁt for replication in macrophages and unﬁt for rep-
lication in enterocytes. The ultimate target cell is not just any mac-
rophage, but rather a distinct population of precursor monocytes/
macrophages that have a speciﬁc aﬃnity for the endothelium of
venules in the serosa, omentum, pleura, meninges and uveal tract.
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It is widely assumed that immunity, when it occurs, is largely
cell-mediated and that the production of antibodies is counterpro-
ductive. Antibodies enhance the uptake and replication of FIPVs in
macrophages and also contribute to a type III hypersensitivity
(antibody-mediated or Arthus-type) vasculitis (Pedersen, 2009). It
is also assumed that much of the pathology occurring in FIP is as-
sociated with howmacrophages respond to viral infection and how
the immune system of the host responds to the infected cells. In
this scenario, the effusive form of FIP results from a failure to mount
T cell immunity in the face of a vigorous B cell response. At the
opposite extreme, cats that resist disease presumably mount a vig-
orous cell-mediated immune response that is able to overcome any
negative effects of antibodies. Cats with the dry form of FIP
represent an intermediate state involving a cellular response that
is partially effective in containing the virus to a relatively small
number of macrophages in a few focal sites within speciﬁc target
organs. The two forms of FIP are somewhat interchangeable; when
it has been observed in experimental infection, the dry form always
follows a brief bout of effusive disease. In the terminal stages of
naturally occurring dry FIP, immunity can completely collapse
and the disease reverts to a more effusive form. Although this sce-
nario ﬁts what is known about FIP, it must be emphasized that much
of this scheme awaits conﬁrmation and there are large gaps to be
ﬁlled.
B cell vs. T cell immunity
An imbalance in T cell vs. B cell immune responses has been
evoked as one reason for the inability of cats to resist FIPV infec-
tion. One study demonstrated that the ratio of peripheral blood
surface immunoglobulin positive cells (sIg+) to CD21+ cells was higher
in cats with FIP than in SPF cats, and that cells strongly expressing
mRNA of the plasma cell master gene encoding B lymphocyte-
inducedmaturation protein 1 (Blimp-1) were increased (Takano et al.,
2009a). ThemRNAs of interleukin 6, CD40 and B cell activating factor
(BAFF) were also overexpressed in macrophages previously shown
to be associated with antibody-dependent enhancement.
Vermeulen et al. (2013) studied the role of natural killer (NK) cells
and regulatory T cells (Tregs) in the innate and adaptive cell-
mediated immunity, respectively, in cats with naturally occurring
FIP. NK cells and Tregs were drastically depleted from the periph-
eral blood,mesenteric lymph nodes and spleen in cats with FIP, while
the mesentery and kidneys from cats with FIP did not show any dif-
ferences when compared to healthy uninfected control cats. Other
regulatory lymphocytes of the CD4+CD25−Foxp3+ and CD3+CD8+Foxp3+
phenotypes were depleted from both blood and lymph nodes. NK
cells in cats with FIP were upregulated for the activation markers
CD16 and CD25, and migration markers CD11b and CD62L, while
NK cells from lymph nodes had upregulation of CD16 and CD62L
only. NK cells from the lymph nodes of cats with FIP also exhib-
ited less cytotoxic activity than NK cells from the lymph nodes of
healthy cats. Therefore, it appears that infection with FIPV is asso-
ciated with severe depletion of both NK cells and Tregs, and reduced
NK cell function. This could reduce the capacity of the innate immune
system to attack the virus and to suppress the associated immu-
nologic and inﬂammatory responses.
The most compelling evidence for the role of T cell immunity in
FIP might actually come from research with a distantly related
coronavirus infection of another species.Mouse hepatitis virus (MHV)
is one of the most common virus models in laboratory mice. MHV,
like FIPV, exists as two biotypes, designated enterotropic and poly-
tropic. Polytropic strains of MHV aremainly of laboratory origin and
cause a variety of hepatic and neurologic syndromes, depending on
the laboratory of origin, in vitro and in vivo passage history, and
inbredmouse strain used for the infection study (Homberger, 1997).
In contrast, enterotropic biotypes tend to predominate in nature.
Most coronavirus contamination in experimental mice colonies is
associated with enterotropic strains of MHV brought in from wild
mice.
Interestingly, certain polytropic laboratory strains of MHV cause
a disease syndrome analogous to FIP of cats when they infect an in-
terferon (IFN)-γ deﬁcient strain of mice (Kyuwa et al., 1998). This
prompted additional comparative studies of enterotropic and poly-
tropic strains of MHV (Compton et al., 2004). Immunocompetent,
as well as B and T cell deﬁcient strains of laboratory mice were in-
fected with an enterotropic strain of MHV, MHV-Y. The infection in
immunocompetent mice was limited to the small intestine for the
ﬁrst week and then to the cecum and colon for the next 2 weeks.
B cell deﬁcient mice also developed chronic subclinical infection re-
stricted to the gastrointestinal tract, but lasting for 7–8 weeks. The
pattern of infection in these two strains of mice was reminiscent
of FECV infection in laboratory cats (Pedersen et al., 2008; Kipar et al.,
2010). In contrast, T cell deﬁcient mice infected with MHV-Y de-
veloped amulti-systemic lethal infection, with virus detected in the
intestine during the ﬁrst week; the mice then developed peritoni-
tis by week 2, with virus detected in mesentery and visceral peri-
toneum, before the mice died by weeks 3–4. These ﬁndings with
MHV strains in inbred strains of mice support the importance of both
IFN-γ and T cell immunity in resistance to FIP. In the mouse model,
it was the host’s response to MHV and not the biotype that deter-
mined the disease form (enteritis or FIP-like disease), while in the
case of FIP, genetic differences between the FECV and FIPV bio-
types determine the host response and disease form (enteritis or
FIP).
The pyogranuloma
The classical lesions of FIP are the pyogranuloma of the effu-
sive form and the somewhatmore typical granuloma of the dry form.
As the name implies, the pyogranuloma is an accumulation of mac-
rophages, neutrophils, lymphocytes and occasional plasma cells that
tend to form small aggregations around venules in the target tissues.
These cells arrive from the bloodstream as a result of upregulation
of both adhesion proteins and their receptors. Olyslaegers et al. (2013)
studied the altered expression of the transmigration adhesion mol-
ecules CD11a, CD11b, CD15s, CD18, CD49d and CD54 on blood leu-
kocytes from cats with naturally occurring FIP. They found that T
and B lymphocytes andmonocytes expressed higher levels of CD11a
and CD18, while B lymphocytes had increased levels of expression
of CD49d and granulocytes had increased levels of expression of
CD11b. It was concluded that all of these blood leukocytes exhib-
ited features of systemic activation in cats with FIP and that this con-
tributed to their transmigration into the pyogranulomas seen in the
disease.
The pyogranuloma is also strongly associated with edema and
the effusion of large volumes of a proteinaceous ﬂuid that is rich
in plasma proteins, hemoglobin breakdown products, inﬂammato-
ry proteins of many types and activated clotting factors. The factors
responsible for this outpouring of ﬂuid have not been identiﬁed
fully, but at least one of these factors appears to be vascular endo-
thelial growth factor (VEGF; Takano et al., 2011a). This is produced
by FIPV infected monocytes and macrophages. Other proteins,
such as tumor necrosis factor (TNF)-α, granulocyte macrophage-
colony stimulating factor (GM-CSF) and granulocyte-colony stimu-
lating factor (G-CSF) are also produced by macrophages in cats
with FIP and are thought to contribute to increased survival of neu-
trophils (Takano et al., 2009b). The p38 mitogen-activated protein
kinase (MAPK) pathway has been shown to play an important role
in the over production of pro-inﬂammatory cytokines in FIPV in-
fected peripheral blood mononuclear cells (PBMCs) (Regan et al.,
2009).
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Cytokines and feline infectious peritonitis
Clinically normal cats living in catteries with enzootic FECV in-
fection overall had higher serum IFN-γ concentrations than cats in
catteries experiencing losses due to FIP and catteries free of infec-
tion (Giordano and Paltrinieri, 2009). IFN-γ concentrations were high
in the sera of cats with FIP, and even higher in body cavity effu-
sions, the latter thought to reﬂect production by local inﬂamma-
tion. It was concluded that FECV-infected cats have a strong systemic
IFN-γ response, while cats with FIP have a strong IFN-γ response at
the tissue level.
A test to measure the ability of leukocytes in whole blood to
produce IFN-γ (protein and mRNA) in vitro in response to eight im-
munogenic peptides derived from the N protein of virulent (FIPVs)
and avirulent (FECVs) feline coronaviruses has been developed for
cats (Rossi et al., 2011). The sequences used were obtained from an
earlier study by Battilani et al. (2010) that compared a small number
of N gene sequences from lesions of cats with FIP and feces of clin-
ically healthy cats, and purported to show N epitopes that would
differentiate the two. The test was applied to a group of healthy cats
and another group with chronic diseases other than FIP. Cats with
chronic diseases other than FIP responded with increases in both
IFN-γ protein and mRNA when exposed to peptides that were pre-
sumed to be speciﬁc for avirulent (FECV) or a mixture of avirulent
(FECV) and virulent (FIPV) epitopes. Unfortunately, no results were
given for cats with FIP.
Satoh et al. (2011a) developed monoclonal antibodies against
feline IFN-γ and used them to study immune responses to FIPV.
PBMCs from cats experimentally infected with FIPV that did not
develop clinical disease had signiﬁcantly increased levels of IFN-γ
production after exposure to heat–inactivated FIPV compared to cats
that died of FIP; the increased IFN-γ levels were more marked in
CD8+ than CD4+ T cells. It was concluded that cell-mediated immu-
nity was important in resistance to FIP.
Dedeurwaerder et al. (2013b) studied the role of the ORF 7a gene
product in antiviral defense. Deletion of ORF 7a and ORF 7b of FIPV
WSU-79-1146 rendered the virus more susceptible to IFN-α treat-
ment in cell culture. They then separately added ORF 7a and ORF
7b back into the mutant virus; ORF 7a, but not ORF 7b, rescued
normal sensitivity to IFN-α. When these insertions were per-
formed in amutant of FIPVWSU-79-1146with deletions of ORF 3abc
and ORF 7ab, sensitivity to IFN-α was not restored. It was con-
cluded that the ORF 7a protein acted as a type I IFN antagonist in
the presence of ORF 3abc protein(s) and protected FIPV against the
effects of this particular host cell antiviral response.
One of the newest approaches to studying immune responses
involves transcriptional proﬁling, wherein the various cellularmRNAs
triggered by a viral infection can be monitored for up- or down-
regulation. Harun et al. (2013) demonstrated the feasibility of such
an approach using CRfk cells exposed to FIPVWSU-79-1146 for 3 h.
Theywere able to detect 18,899 of the 19,046 annotated feline genes.
Based on results from their culture studies and Kal’s Z test, 44 genes
were upregulated, 61 genes were not affected by virus infection
and the remaining genes were down-regulated. This transcrip-
tional proﬁle was used to identify three genes (A3H, PD-1 and PD-
L1) that were both upregulated and potentially relevant to FIP. A
real-time (RT)-PCR was than developed for each gene, and the level
of expression in PBMCs from seven cats with conﬁrmed FIP was
measured. Upregulation of cDNAs from the three genes was ob-
served, but it tended to be low and highly variable between
individual genes, as well as cats. Although this study did not report
details on the number of replicates used in various parts of the
study, and could have used actual normal and diseased tissues/
cells in preference to experimentally infected and non-infected
CRfk cells, it is an approach that will be applied much more in the
future.
Antibody-dependent enhancement
There is ample evidence from experimental studies that FIPV in-
fection is greatly enhanced in the presence of coronavirus antibod-
ies, whether they are actively elicited by exposure to FECV or
avirulent FIPVs, or passively administered in the form of immune
serum from either FECV- or FIPV-infected cats (Pedersen, 2009). This
antibody-dependent enhancement (ADE) is best demonstratedwhen
the antibody and challenge strain of FIPV are of similar type (Takano
et al., 2008). This ADE is not unique to feline coronaviruses and has
been the bane of vaccines used or tested in the ﬁeld against dengue
virus, feline immunodeﬁciency virus and human immunodeﬁ-
ciency virus type 1 (HIV-1) (Huisman et al., 2009).
The exact anti-coronavirus epitopes responsible for ADE have
been somewhat elusive, but they appear to reside in the S protein.
Satoh et al. (2011b) synthesized 81 peptides from the S2 region of
the S protein of a type I FIPV (KU-2) and type II FIPV (WSU-79-
1146), and from the N protein of FIPV KU-2. They used these pep-
tides to stimulate IFN-γ production from PBMCs of cats
experimentally infected with FIPV and identiﬁed a number of linear
immunodominant antibody-binding epitopes at different posi-
tions in the S2 and N regions within both type I and type II FIPVs.
Satoh et al. (2010) also studied three baculovirus expressed pro-
teins derived from different regions of the S2 domain of the S protein
of the type I FIPV KU-2 strain. One of these proteins, which spanned
the region from the fusion peptide to the heptad repeat 2 region,
induced a vigorous T helper type 1 (Th1) and T helper type 2 (Th2)
immune response in mice. Out of 30 peptides derived from this
region that were tested in mice, four peptides that included both
Th1 and Th2 epitopes were identiﬁed; the authors concluded
that these regions should be explored in cats as potential
immunogens.
Takano et al. (2011b) also studied the putative ADE epitopes in
FIPVWSU-79-1146 with a battery of monoclonal antibodies against
the virus neutralizing epitope on the S protein. Virus cultures exposed
to one of these monoclonal antibodies eventually yielded a virus
with two amino acid changes in the neutralizing epitope of the S
protein that rendered it resistant to neutralization. In the process,
the monoclonal antibody used to produce this mutant also lost its
ability to enhance the replication of homologous virus, thus sug-
gesting that virus neutralization and ADE were present in the same
region of the S protein. The mutant virus used in the study also rep-
licated to lower levels in monocyte/macrophages.
Evasion of antibody-dependent, complement-mediated lysis has
been studied in CRfk cells and monocytes infected with FIPVWSU-
79-1146 and an ORF 3abc/ORF 7b deletionmutant (Cornelissen et al.,
2009). Surface expression of viral proteins by infected cells, whether
by wild type FIPV or the deletion mutant, prevented complement-
mediated lysis, even though controls showed it to be functional. The
authors postulated that this was a newmechanism for FIPV to evade
the immune system.
A different evasion routewas proposed by Dewerchin et al. (2008).
Monocytes infected with FIPV express viral proteins on their plasma
membranes; upon binding of antibodies, these proteins are rapidly
internalized through a clathrin- and caveolae-independent pathway,
which is also dependent on dynamin (Van Hamme et al., 2008). In
doing so, the infected monocytes can escape antibody-dependent
cell lysis. In a subsequent study, Dewerchin et al. (2014) identiﬁed
kinases and cytoskeletal proteins that were involved in internal-
ization and subsequent intracellular transport of FIPV. Myosin light
chain kinase and myosin 1 were crucial for the initiation of the in-
ternalization process, as shown by the co-localization of both pro-
teins with antigens prior to virus internalization. One minute after
internalization commenced, the virus-laden vesicles had co-
localized with microtubules and accumulated at the microtubule
organizing center after 10–30min. This activity of myosin light chain
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kinase was effectively inhibited by ML-7, thus identifying a possi-
ble target for an anti-viral drug.
How do feline coronaviruses enter their host cells?
Themechanism bywhich the various feline coronaviruses attach
to their host cells is not known. Type II FIPVs appear to utilize ami-
nopeptidase N as their principal receptor. While the primary re-
ceptor for type I feline coronaviruses is unknown, the lectin dendritic
cell-speciﬁc intercellular adhesion molecule-3-grabbing non-
integrin (DC-SIGN, CD209) can act as a co-receptor (Regan and
Whittaker, 2008; Regan et al., 2010). These receptors are undoubt-
edly important for FECV binding to target enterocytes, but whether
they play a role in infection of macrophages by FIPVs is unknown.
It is possible that FIPVs could enter their target macrophages using
less speciﬁc means, such as through the Fc-receptors used for com-
plement binding.
Vaccines against feline infectious peritonitis
A spate of papers describing possible vaccines against FIP has ap-
peared over the last three decades (Pedersen, 2009). Several re-
portedly showed protection, but only one of doubtful eﬃcacy went
into commercial production. However, recently there has been a
renewed interest in FIP vaccines. Bálint et al. (2013) developed a
vaccine based on a pair of recombinant viruses derived from the type
II FIPV strain DF2, a virus nearly identical to FIPVWSU-79-1146. One
strain was avirulent and the other of low virulence. SPF cats ap-
peared to be fully protected against virulent FIPV DF2 after two
oronasal and two intramuscular injections 2 weeks apart. Surpris-
ingly, purebred British shorthair cats were not protected following
the same vaccine regimen, although experimental and control groups
were small. Vaccination with the avirulent virus induced ADE and,
following challenge-exposure, all cats developed FIP; 40% of cats had
prolonged survival, while 60% died from fulminant disease. The re-
searchers evoked differences between conventional and SPF cats,
as well as heterologous virus pre-exposure, as reasons for the various
experimental outcomes.
Takano et al. (2014a) immunized cats with Th1 stimulating pep-
tides identiﬁed previously in the N protein of the type I FIPV strain
KU-2 using feline CpG-oligodeoxynucleotides (fCpG-ODNs) as ad-
juvants. Some immunity was demonstrated against challenge-
exposure with the type II FIPV strain WSU-79-1146, but immune
tolerance was also observed at higher vaccine dosages. The re-
searchers concluded that further investigations on the combina-
tion and concentrations of the peptides and fCpG-ODNs, along with
dose, frequency and route of administration, were needed. Takano
et al. (2014b) identiﬁed strong Th1 epitopes within the S1 domain
of the S protein and in the M protein of both type I (KU-2) and type
II (WSU-79-1146) FIPVs. Interestingly, no immunodominant anti-
body binding Th1 epitope-containing peptide was identiﬁed in the
primary antibody binding S1 domain of the type II FIPV. Eleven Th1
epitope-containing peptides were identiﬁed in the S, M and N pro-
teins that were common to both type I and type II FIPVs. Three of
these peptides were administered with CpG-ODNs to SPF cats; two
of these peptides from the S1 and M proteins induced Th1 activity
to peptide stimulation of PBMC cultures, but no cat infection results
were reported.
Is there a genetic susceptibility to FIP disease?
Early research strongly suggested that susceptibility to FIP might
be controlled to some extent by genetic factors (Pedersen, 2009).
A genome-wide association study of a relatively large number of
Birman cats identiﬁed ﬁve regions on four different chromosomes
that could harbor genes involved in susceptibility (Golovko et al.,
2013). Five candidate genes (ELMO1, RRAGA, TNSF10, ERAP1 and
ERAP2) were identiﬁed in these four regions; all are associated with
processes relevant to FIP, such as cellular migration, phagocytosis,
apoptosis and virus–host interactions. These associations require con-
ﬁrmation and further study, as they might only be relevant to one
breed. If genetics are involved in the disease, as it appears, the exact
genes and pathways involved appear to be numerous and, there-
fore, inheritance is likely to be complex.
Conclusions
We are rapidly gaining a better understanding of the muta-
tional events that cause FECVs to become FIPVs, but we lack knowl-
edge of how these mutations are involved in immunopathogenesis.
At least three separate types of mutations have been associated with
the acquisition of FIP virulence and more are likely to be discov-
ered. Cell lines that will replicate FECVs in vitro have been devel-
oped and this, coupled with the creation of infectious molecular
clones of FIPV, will hopefully allow us to assess the importance of
these and any future mutations. A number of new reagents and pro-
cedures have given us a window into the cells involved in the in-
ﬂammatory and immune responses that characterize the two distinct,
yet overlapping, clinical forms of FIP. Other environmental and host
factors undoubtedly play a role in determining the outcome of ex-
posure, but their roles are not understood. The elaboration of various
cytokines and other inﬂammatory proteins in the FIP disease process
has been extensively studied, but how these various factors are
stimulated and their role in pathology is poorly understood. A pos-
sible role for genetic susceptibility has been identiﬁed in at least one
breed of cats, but the genetics appear to be highly complex and
cannot explain the entire disease incidence. A more parsimonious
conclusion is that FIP results from a conﬂuence of numerous viral,
host and environmental factors akin to the ‘perfect storm’. Al-
thoughwe are heartened by our increasing knowledge of this disease,
we are continually reminded of thewords of Robert Frost in his poem
‘The Secret Sits’: ‘We dance round in a ring and suppose, but the secret
sits in the middle and knows.’
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